Novel treatments for castration-resistant prostate cancer

被引：4
|
作者：
Sternberg, Cora N. [1 ]
机构：
[1] San Camillo & Forlanini Hosp, Dept Med Oncol, Rome, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)70165-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The contemporary management of metastatic castration-resistant prostate cancer (mCRPC) is evolving dramatically. Understanding the biology of this disease, positive phase III studies and approvals for 4 novel agents in the US in 2010 and shortly in Europe have dramatically changed the therapeutic landscape.
引用
收藏
页码：S195 / S199
页数：5
相关论文
共 50 条
  • [21] Castration-resistant prostate cancer (CRPC)
    Loidl, W.
    Luger, F.
    Roosen, A.
    UROLOGE, 2014, 53 (03): : 391 - 399
  • [22] Novel therapeutic approaches for the treatment of castration-resistant prostate cancer
    Heidegger, Isabel
    Massoner, Petra
    Eder, Iris E.
    Pircher, Andreas
    Pichler, Renate
    Aigner, Friedrich
    Bektic, Jasmin
    Horninger, Wolfgang
    Klocker, Helmut
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 138 : 248 - 256
  • [23] Novel agents and new therapeutics in castration-resistant prostate cancer
    Wu, Yichao
    Rosenberg, Jonathan E.
    Taplin, Mary-Ellen
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (03) : 290 - 296
  • [24] Novel approaches and future directions in castration-resistant prostate cancer
    Nabhan, C.
    Parsons, B.
    Touloukian, E. Z.
    Stadler, W. M.
    ANNALS OF ONCOLOGY, 2011, 22 (09) : 1948 - 1957
  • [25] Kaiso as a novel therapeutic target in castration-resistant prostate cancer
    Lin, Huixian
    Wang, Honghe
    White, Jason
    Karanam, Balasubramanyam
    Ghebremedhin, Anghesom
    Adu-Addai, Benjaminal
    Grizzle, William
    Yates, Clayton
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [26] Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)
    Lee, Daniel J.
    Cha, Eugene K.
    Dubin, Justin M.
    Beltran, Himisha
    Chromecki, Thomas F.
    Fajkovic, Harun
    Scherr, Douglas S.
    Tagawa, Scott T.
    Shariat, Shahrokh F.
    BJU INTERNATIONAL, 2012, 109 (07) : 968 - +
  • [27] Steroidogenesis in castration-resistant prostate cancer
    Shiota, Masaki
    Endo, Satoshi
    Blas, Leandro
    Fujimoto, Naohiro
    Eto, Masatoshi
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 240 - 251
  • [28] Cabazitaxel for castration-resistant prostate cancer
    Shigeta, Keisuke
    Miura, Yuji
    Naito, Yoichi
    Takano, Toshimi
    LANCET, 2011, 377 (9760): : 121 - 121
  • [29] Enzalutamide in castration-resistant prostate cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2014, 15 (08): : E312 - E312
  • [30] Denosumab in castration-resistant prostate cancer
    Kyrgidis, Athanassios
    Tzellos, Thrasivoulos-George
    LANCET, 2012, 379 (9828): : E50 - E50
12345